• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

卡利拉嗪添加治疗合并精神分裂症的强迫症快速起效:1 例个案报告。

Rapid improvement of obsessive-compulsive disorder associated with schizophrenia with cariprazine add-on in a subject under paliperidone long-acting injection: a case report.

机构信息

National Health Service, Department of Mental Health, Psychiatric Service of Diagnosis and Treatment, Hospital 'G. Mazzini,' ASL 4 Teramo.

Department of Neurosciences and Imaging, Chair of Psychiatry, University 'G. D'Annunzio,' Chieti.

出版信息

Int Clin Psychopharmacol. 2020 Mar;35(2):113-118. doi: 10.1097/YIC.0000000000000284.

DOI:10.1097/YIC.0000000000000284
PMID:32004167
Abstract

Obsessive-compulsive disorder is often associated with schizophrenia and may represent a significant challenge in the treatment as this comorbidity may not respond properly to antipsychotic medication and usually require a pharmacological and psychotherapeutic add-on. In the present case report, we present the case of a 26-year-old male blue-collar subject who developed obsessive-compulsive disorder after a year of complete remission of schizophrenia symptoms under paliperidone long-acting injection that rapidly resolved after low-dosage cariprazine add-on. No adverse effects were reported due to cariprazine- paliperidone long-acting injection combination.

摘要

强迫症常与精神分裂症相关,且可能在治疗中构成重大挑战,因为这种合并症可能不能对抗精神病药物治疗产生适当的反应,通常需要药物和心理治疗的辅助。在本病例报告中,我们报告了 1 例 26 岁男性蓝领工人的病例,他在长效帕利哌酮注射治疗下精神分裂症症状完全缓解 1 年后出现强迫症,加用低剂量卡利拉嗪后迅速缓解。由于卡利拉嗪-长效帕利哌酮联合使用,未报告不良反应。

相似文献

1
Rapid improvement of obsessive-compulsive disorder associated with schizophrenia with cariprazine add-on in a subject under paliperidone long-acting injection: a case report.卡利拉嗪添加治疗合并精神分裂症的强迫症快速起效:1 例个案报告。
Int Clin Psychopharmacol. 2020 Mar;35(2):113-118. doi: 10.1097/YIC.0000000000000284.
2
Emerging pharmacological therapies in schizophrenia: what's new, what's different, what's next?精神分裂症的新兴药物治疗:新在哪里,有何不同,未来走向如何?
CNS Spectr. 2016 Dec;21(S1):1-12. doi: 10.1017/S1092852916000729.
3
Obsessive-compulsive symptoms induced by long-acting injectable paliperidone in a patient with schizophrenia: a case report.长效注射用帕利哌酮致精神分裂症患者出现强迫症状:一例报告
Ann Clin Psychiatry. 2014 Nov;26(4):301-2.
4
Paliperidone Long-Acting Plasma Level Monitoring and a New Method of Evaluation of Clinical Stability.帕利哌酮长效血药浓度监测及临床稳定性评估新方法
Pharmacopsychiatry. 2017 Jul;50(4):145-151. doi: 10.1055/s-0037-1601396. Epub 2017 Mar 9.
5
Paliperidone in Obsessive-Compulsive Disorder: A Case Study.帕利哌酮治疗强迫症:一项病例研究。
J Clin Psychopharmacol. 2020 Mar/Apr;40(2):205-207. doi: 10.1097/JCP.0000000000001181.
6
Effectiveness of aripiprazole in treating obsessive compulsive symptoms.阿立哌唑治疗强迫症状的疗效。
Prog Neuropsychopharmacol Biol Psychiatry. 2008 Feb 15;32(2):585-6. doi: 10.1016/j.pnpbp.2007.10.009. Epub 2007 Oct 23.
7
Cognitive function and risperidone long-acting injection vs. paliperidone palmitate in schizophrenia: a 6-month, open-label, randomized, pilot trial.精神分裂症中认知功能与利培酮长效注射剂对比棕榈酸帕利哌酮:一项为期6个月的开放标签随机试点试验
BMC Psychiatry. 2016 May 29;16:172. doi: 10.1186/s12888-016-0883-9.
8
Impact of paliperidone palmitate one-month formulation on relapse prevention in patients with schizophrenia: A post-hoc analysis of a one-year, open-label study stratified by medication adherence.棕榈酸帕利哌酮单月制剂对精神分裂症患者复发预防的影响:一项为期一年、开放性研究的事后分析,按药物依从性分层。
J Psychopharmacol. 2018 Jun;32(6):691-701. doi: 10.1177/0269881118772449. Epub 2018 May 16.
9
Need for Bioequivalence Standards that Reflect the Clinical Importance of the Complex Pharmacokinetics of Paliperidone Palmitate Long-Acting Injectable Suspension.需要反映棕榈酸帕利哌酮长效注射混悬剂复杂药代动力学的临床重要性的生物等效性标准。
J Pharm Pharm Sci. 2019;22(1):548-566. doi: 10.18433/jpps30669.
10
Paliperidone palmitate: effectiveness, safety, and the use for treatment of schizophrenia.棕榈酸帕利哌酮:疗效、安全性及在精神分裂症治疗中的应用
Psychiatr Pol. 2017 Feb 26;51(1):7-21. doi: 10.12740/PP/64581.

引用本文的文献

1
Cariprazine and clozapine: a systematic review of a promising antipsychotic combination for treatment-resistant schizophrenia.卡立哌嗪与氯氮平:对一种有前景的用于治疗难治性精神分裂症的抗精神病药物组合的系统评价
Int J Neuropsychopharmacol. 2025 Aug 1;28(8). doi: 10.1093/ijnp/pyaf053.
2
Unraveling the Boundaries, Overlaps, and Connections between Schizophrenia and Obsessive-Compulsive Disorder (OCD).解析精神分裂症与强迫症(OCD)之间的界限、重叠及关联
J Clin Med. 2024 Aug 12;13(16):4739. doi: 10.3390/jcm13164739.
3
[Obsessive-compulsive symptoms in psychotic disorders: pathogenesis and treatment].
[精神障碍中的强迫症状:发病机制与治疗]
Nervenarzt. 2022 Jul;93(7):688-694. doi: 10.1007/s00115-022-01332-z. Epub 2022 Jul 5.
4
Real-Life Clinical Experience With Cariprazine: A Systematic Review of Case Studies.卡立普嗪的真实临床经验:病例研究的系统评价
Front Psychiatry. 2022 Mar 17;13:827744. doi: 10.3389/fpsyt.2022.827744. eCollection 2022.
5
Improving Mood and Cognitive Symptoms in Huntington's Disease With Cariprazine Treatment.使用卡立普嗪治疗改善亨廷顿舞蹈病的情绪和认知症状
Front Psychiatry. 2022 Feb 10;12:825532. doi: 10.3389/fpsyt.2021.825532. eCollection 2021.
6
Cariprazine Use in Early Psychosis: Three Case Reports.卡立普嗪用于早期精神病:三例病例报告。
Front Psychiatry. 2021 Dec 16;12:788281. doi: 10.3389/fpsyt.2021.788281. eCollection 2021.
7
Cariprazine: Patients with Treatment-Resistant Schizophrenia.卡立普嗪:难治性精神分裂症患者。
Neuropsychiatr Dis Treat. 2021 Jul 14;17:2327-2332. doi: 10.2147/NDT.S315653. eCollection 2021.
8
Cariprazine Add-on in Inadequate Clozapine Response: A Report on Two Cases.卡立普嗪辅助治疗氯氮平反应欠佳:两例报告
Clin Psychopharmacol Neurosci. 2021 Feb 28;19(1):174-178. doi: 10.9758/cpn.2021.19.1.174.
9
An Obsessive-Compulsive Symptom-Related Headache in a Patient with Schizophrenia.一名精神分裂症患者的强迫症状相关性头痛
Case Rep Psychiatry. 2020 Oct 10;2020:8824204. doi: 10.1155/2020/8824204. eCollection 2020.